Artiva Biotherapeutics (ARTV) EBT (2023 - 2024)
Historic EBT for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to -$16.1 million.
- Artiva Biotherapeutics' EBT fell 4130.15% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 12819.39% down from last year.
- According to the latest figures from Q4 2024, Artiva Biotherapeutics' EBT is -$16.1 million, which was down 4130.15% from -$16.5 million recorded in Q3 2024.
- In the past 5 years, Artiva Biotherapeutics' EBT registered a high of $11.2 million during Q3 2023, and its lowest value of -$16.5 million during Q3 2024.